Literature DB >> 2807780

The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).

F Gaboardi1, R Bordinazzo, L Galli.   

Abstract

The aim of this report is to emphasize the use of methylene staining test and the Nd:YAG laser in the diagnosis and treatment of premalignant lesions and CIS of the bladder. The use of an appropriate solution of methylene blue (0.2% in 0.9 M NaCl for 15 min) permits the staining of premalignant areas and CIS, and their early diagnosis. Laser irradiation of the stained areas facilitates the treatment of lesions. The technique was utilized in 8 patients without noteworthy side effects. It allowed an adequate treatment of the lesions and provided good results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807780     DOI: 10.1007/bf02559739

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: progress report.

Authors:  L G Koss; M R Melamed; E Kelly
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

Review 2.  Photoradiation therapy.

Authors:  T J Dougherty
Journal:  Urology       Date:  1984-03       Impact factor: 2.649

Review 3.  Rationale for intensive intravesical chemotherapy for superficial bladder cancer.

Authors:  M S Soloway
Journal:  J Urol       Date:  1980-04       Impact factor: 7.450

4.  In vivo urothelial surface histology by microscopic chromocystoscopy.

Authors:  W B Gill; J L Huffman; E S Lyon; D H Bagley
Journal:  J Urol       Date:  1983-10       Impact factor: 7.450

Review 5.  Urothelial dysplasia.

Authors:  W M Murphy; M S Soloway
Journal:  J Urol       Date:  1982-05       Impact factor: 7.450

6.  Significance of carcinoma in situ and dysplasia in association with bladder cancer.

Authors:  T Kakizoe; K Matumoto; Y Nishio; M Ohtani; K Kishi
Journal:  J Urol       Date:  1985-03       Impact factor: 7.450

7.  In vivo staining test with methylene blue for bladder cancer.

Authors:  I Fukui; M Yokokawa; G Mitani; F Ohwada; M Wakui; M Washizuka; T Tohma; K Igarashi; T Yamada
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

8.  Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.

Authors:  U O Nseyo; T J Dougherty; D G Boyle; W R Potter; R Wolf; R Huben; J E Pontes
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

9.  Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy.

Authors:  R C Benson; J H Kinsey; D A Cortese; G M Farrow; D C Utz
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

10.  Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer.

Authors:  A Tsuchiya; N Obara; M Miwa; T Ohi; H Kato; Y Hayata
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.